Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HV.1.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HV.1.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HV.1.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HV.1.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HV.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.15.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.15.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.15.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.15.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.15.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.15.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JD.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JD.1.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JD.1.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JD.1.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JD.1.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.637EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
B.1.637EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
B.1.637ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
B.1.637ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.637EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
B.1.637EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.637ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.637ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
AY.39 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.39 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.39 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used